drugset / Trial / NCT07479667
An Antibody-armored Dendritic Cell in Patients With Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is a single-arm, open-label, single-administration dose-escalation study.
Timeline
- Start
- 2026-02-05
- Primary completion
- 2028-12-31
- Completion
- 2029-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Armored Dendritic Cell Injection | Cell therapy | — | Subcutaneous |
Indications
No indication recorded.